{"total":90,"page":1,"pageSize":25,"pages":4,"millis":13,"query":{"q":"health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-002","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19, 85 Fed. Reg. 19392 (Apr. 7, 2020)","title":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19","dateIssued":"2020-04-02","startDate":"2020-04-02","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-002","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-002"},{"id":"AGY-FED-HEALTH-OTHER-021","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213)","instrument":"DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider\u0027s DEA-registered location during the COVID-19 public health emergency","title":"Administering Certain CS in the parking lot of a healthcare provider\u0027s DEA-registered location during the COVID-19 public health emergency","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-021","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-021"},{"id":"AGY-FED-HEALTH-OTHER-001","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 22024 (Apr. 21, 2020)","title":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-03-17","startDate":"2020-03-17","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-001","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-001"},{"id":"AGY-FED-HEALTH-OTHER-043","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)","title":"Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency","dateIssued":"2020-03-22","startDate":"2020-03-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-043","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-043"},{"id":"AGY-FED-HEALTH-OTHER-003","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)","title":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-04-09","startDate":"2020-04-09","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-003","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-003"},{"id":"AGY-FED-HEALTH-OTHER-038","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)","title":"Determination of Public Health Emergency","dateIssued":"2020-02-04","startDate":"2020-02-04","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["EMER","SUPPLY"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-038","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-038"},{"id":"AGY-FED-HEALTH-OTHER-006","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Melanie Fontes Rainer, Director, Office for Civil Rights, HHS","instrument":"Notice of Expiration of Certain Notifications of Enforcement Discretion Issued in Response to the COVID-19 Nationwide Public Health Emergency, 88 Fed. Reg. 22380 (Apr. 13, 2023)","title":"Notice of Expiration of Certain Notifications of Enforcement Discretion Issued in Response to the COVID-19 Nationwide Public Health Emergency","dateIssued":"2023-04-11","startDate":"2023-04-13","endDate":"2023-08-09","quarters":[],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-006","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-006"},{"id":"AGY-FED-HEALTH-OTHER-044","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)","title":"Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2023-09-05","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","MASK","OTHER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-044","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-044"},{"id":"AGY-FED-HEALTH-OTHER-061","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs (Robert L. Wilkie, Secretary)","instrument":"Interim Final Rule, Authority of VA Professionals To Practice Health Care, 85 Fed. Reg. 71838 (Nov. 12, 2020)","title":"Authority of VA Professionals To Practice Health Care","dateIssued":"2020-11-12","startDate":"2020-11-12","endDate":"2021-09-30","quarters":["2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-061","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-061"},{"id":"AGY-FED-HEALTH-OTHER-005","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Robinsue Frohboese, Acting Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination During the COVID-19 Nationwide Public Health Emergency, 86 Fed. Reg. 11076 (Feb. 24, 2021)","title":"Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination","dateIssued":"2021-01-19","startDate":"2020-12-11","endDate":"2023-05-11","quarters":["2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-005","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-005"},{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015"},{"id":"AGY-FED-HEALTH-OTHER-027","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA","instrument":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","title":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-027","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-027"},{"id":"AGY-FED-HEALTH-OTHER-041","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-041","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-041"},{"id":"AGY-FED-HEALTH-OTHER-042","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-042","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-042"},{"id":"AGY-FED-HEALTH-OTHER-046","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency (Apr. 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency","dateIssued":"2020-04-01","startDate":"2020-04-01","endDate":"2023-11-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-046","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-046"},{"id":"AGY-FED-HEALTH-OTHER-069","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs, Veterans Health Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denis McDonough, Secretary of Veterans Affairs","instrument":"VA announcement of July 26, 2021: COVID-19 vaccination mandatory for Title 38 VHA health care personnel within eight weeks","title":"VA mandates COVID-19 vaccines among its medical employees including VHA facilities staff","dateIssued":"2021-07-26","startDate":"2021-07-26","endDate":"2021-09-30","quarters":["2021Q3"],"types":["VAX","HC","EMP"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-069","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-069"},{"id":"AGY-FED-HEALTH-OTHER-058","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Indian Health Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Indian Health Service (Principal Deputy Director Rear Adm. Michael D. Weahkee)","instrument":"IHS Coronavirus (COVID-19) News page listing the Tribal and Urban Indian Organization Leader letters of Mar. 9, 16, 23 and 27, 2020 (archived Mar. 29, 2020)","title":"Coronavirus (COVID-19) / News: Tribal and Urban Indian Organization Leader Messages on COVID-19","dateIssued":"2020-03-29","startDate":"2020-03-29","endDate":"2020-06-30","quarters":["2020Q2"],"types":["HC","EMER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-058","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-058"},{"id":"AGY-FED-HEALTH-OTHER-070","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs, Veterans Health Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denis McDonough, Secretary of Veterans Affairs","instrument":"VA announcement of Aug. 12, 2021: vaccine mandate expanded effective Aug. 13, 2021 to most VHA employees and to volunteers and contractors who work in or visit VHA facilities or come into contact with VA patients and health care workers","title":"VA expands mandate for COVID-19 vaccines among VHA employees","dateIssued":"2021-08-12","startDate":"2021-08-13","endDate":"2021-09-30","quarters":["2021Q3"],"types":["VAX","HC","EMP"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-070","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-070"},{"id":"AGY-FED-HEALTH-OTHER-118","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Secretary of Health and Human Services (terms administered by HRSA)","instrument":"Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution","title":"Acceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-118","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-118"},{"id":"AGY-FED-HEALTH-OTHER-045","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-045","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-045"},{"id":"AGY-FED-HEALTH-OTHER-032","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)","title":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement Amendments Prior to Emergency Use Authorization for Coronavirus Disease-2019","dateIssued":"2020-02-29","startDate":"2020-02-29","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-032","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-032"},{"id":"AGY-FED-HEALTH-OTHER-052","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Jacqueline A. O\u0027Shaughnessy, Acting Chief Scientist, FDA (letter to CDC)","instrument":"Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)","title":"Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021)","dateIssued":"2021-07-12","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-052","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-052"},{"id":"AGY-FED-HEALTH-OTHER-040","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)","title":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19","dateIssued":"2020-03-10","startDate":"2020-02-04","endDate":"2020-10-20","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","EMER","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-040","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-040"},{"id":"AGY-FED-HEALTH-OTHER-025","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies","instrument":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","title":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-025","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-025"},{"id":"AGY-FED-HEALTH-OTHER-026","kind":"order","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA (Assistant Secretary for Mental Health and Substance Use)","instrument":"Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptions","title":"Opioid Treatment Program (OTP) Guidance","dateIssued":"2020-03-16","startDate":"2020-03-16","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-026","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-026"}],"facets":{"kind":[{"value":"order","label":"Order","count":70},{"value":"context","label":"Context (guidance or announcement)","count":20}],"level":[{"value":"federal","label":"Federal","count":90}],"state":[],"type":[{"value":"OTHER","label":"Other","count":53},{"value":"HC","label":"Health care orders","count":49},{"value":"SUPPLY","label":"Supply chain","count":23},{"value":"TELE","label":"Telework mandate","count":15},{"value":"GATH","label":"Gathering cap","count":9},{"value":"EMER","label":"Emergency declaration","count":8},{"value":"EMP","label":"Workplace rules","count":7},{"value":"QUAR","label":"Quarantine and isolation","count":6},{"value":"SCH","label":"Schools and child care","count":6},{"value":"TRAV","label":"Travel and quarantine","count":6},{"value":"CLOSE","label":"Business closure","count":5},{"value":"MASK","label":"Face-covering requirement","count":4},{"value":"CRT","label":"Courts and public offices","count":3},{"value":"VAX","label":"Vaccination or testing","count":3},{"value":"CAP","label":"Capacity limit","count":1},{"value":"EVT","label":"Events and venues","count":1}],"quarter":[{"value":"2021Q3","label":"2021 Q3","count":68},{"value":"2020Q2","label":"2020 Q2","count":62},{"value":"2021Q1","label":"2021 Q1","count":62},{"value":"2021Q2","label":"2021 Q2","count":62},{"value":"2020Q4","label":"2020 Q4","count":61},{"value":"2020Q3","label":"2020 Q3","count":59}],"grade":[{"value":"primary","label":"Primary source read","count":87},{"value":"secondary","label":"Confirmed from a secondary source","count":3}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":90}]}}